Location: Boston, MA
CIK: 0001040508 · Show all filings
Period: Q3 2023 (← Previous) (Next →)
Filing Date: Nov 14, 2023
Total Value: $3.123B (100.0% shares, 0.0% debt)
| Ticker | Issuer | Shares | Value | % | Est. Cost | Unrealized | Class | CUSIP |
|---|---|---|---|---|---|---|---|---|
| SGRY | SURGERY PARTNERS INC | 58,248,249 | $1.704B | 54.6% | $31.75 | +13.2% | COM | 86881A100 |
| — | CEREVEL THERAPEUTICS HLDNG I | 60,199,729 | $1.314B | 42.1% | $16.58 | — | COM | 15678U128 |
| AVAH | AVEANNA HEALTHCARE HLDGS INC | 81,600,880 | $97.11M | 3.1% | $11.86 | -86.9% | COM | 05356F105 |
| ADV | ADVANTAGE SOLUTIONS INC | 2,890,000 | $8.208M | 0.3% | $10.52 | -74.8% | COM CL A | 00791N102 |